Browse by intervention

Vitamin D3: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve in Issue 01. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

Research issue
Issue 01
Data through
2026-08-09
Evidence map version
v1.1.0

How to read this

Phoenix research is longitudinal and observational: we follow real APOE4 carriers over time and compare each member with their own earlier self, with no placebo group, no randomisation, and members choosing their own interventions.

That means these are strong signals pointing at what to test next, not proof of cause. Most nutrition, supplement and lifestyle research you read online has exactly the same design. The difference is that we say so, and we show you the confounders.

Read the full methods and limits

What the Phoenix community is measuring

Browse exact outcomes and interventions. Each result keeps its source, measurement rule and audit record beside the claim.

Vitamin D3 evidence dossier

Evidence collected through 2026-08-09.

What may work against

LDL cholesterol

Laboratory LDL cholesterol result · Aim: lower

Vitamin D3

Opposite direction

One clean curated APOE4/4 case moved opposite the goal, with LDL cholesterol rising 26% across 191 days.

Selected member cases

  1. Vitamin D LDL case · APOE4/4 · female · age not disclosed

    LDL cholesterol rose 26% across a 191-day clean Vitamin D3 window; paired values were not printed.

    What else changed: no nearby starts were recorded.

    Next study: A human repletion trial did not improve lipids and LDL was nonsignificantly higher, making a negative or null Phoenix replication plausible.

1 selected member case · not a response rate

Logged members
159
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Members with a logged Vitamin D3 start and repeat LDL result; the visible case is curated.

  • report-lines-248-343, reviewed by independent verifier

1 selected case shown with this evidence.

Not yet measured

A human repletion trial did not improve lipids and LDL was nonsignificantly higher, making a negative or null Phoenix replication plausible.

How to test it

Baseline
Record LDL cholesterol before the dated Vitamin D3 start.
Duration
84 days
Adherence
Record dose and adherence throughout the window.
Retest
Repeat LDL cholesterol after 12 weeks.
Falsifier
A predeclared Vitamin D3 cohort consistently lowers LDL cholesterol beyond the planned direction-only test.
Eligible-member target
40 members

Still unanswered

Vitamin D level

Laboratory 25-hydroxy vitamin D result · Aim: higher

Vitamin D3

?Collecting evidence

The support cohort has 159 Vitamin D3-family users and 44 with a repeat level, but dated starts and clean eligibility are not published.

0 selected member cases · not a response rate

Logged members
159
Members with repeats
44
Measurements
88
Sources and context

Members matched to the Vitamin D3 support family for the repeat 25-hydroxy vitamin D question.

  • report-lines-129-156, reviewed by independent verifier

Collecting evidence

No answer yet on Vitamin D level

Vitamin D3 is being tracked against Vitamin D level, but Phoenix has not yet published a ranked result for this exact question.

Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.

Topic-specific updates about Vitamin D3 · No spam
Keep the map

Take every result into your next experiment.

Get the Issue 01 Evidence Map by email. It groups the same evidence by outcome and by intervention, including what worked, what did not, and what Phoenix wants to test next.

Instant PDF · Issue 02 lands in your inbox the day it publishes · No spam

Turn evidence into your next test

Magnesium and homocysteine is 7 members from an answer.

Forty carriers with a dated start and a repeat blood test close it. Creatine, vitamin D3 and B12 sit further back. Your next blood test is somebody else's answer, and theirs is yours.

Take the 7-minute assessment